Forskning ved Københavns Universitet - Københavns Universitet

Forside

Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Fusidic acid for Behçet's colitis : a novel approach to T-cell specific immunosuppressive therapy. / Langholz, E; Brynskov, J; Freund, L G; Bendtzen, K.

I: Danish Medical Bulletin (Print), Bind 38, Nr. 3, 06.1991, s. 284.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Langholz, E, Brynskov, J, Freund, LG & Bendtzen, K 1991, 'Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy', Danish Medical Bulletin (Print), bind 38, nr. 3, s. 284.

APA

Langholz, E., Brynskov, J., Freund, L. G., & Bendtzen, K. (1991). Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy. Danish Medical Bulletin (Print), 38(3), 284.

Vancouver

Langholz E, Brynskov J, Freund LG, Bendtzen K. Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy. Danish Medical Bulletin (Print). 1991 jun;38(3):284.

Author

Langholz, E ; Brynskov, J ; Freund, L G ; Bendtzen, K. / Fusidic acid for Behçet's colitis : a novel approach to T-cell specific immunosuppressive therapy. I: Danish Medical Bulletin (Print). 1991 ; Bind 38, Nr. 3. s. 284.

Bibtex

@article{07cf1f48b37a4ebe8e65271531e4211f,
title = "Fusidic acid for Beh{\c c}et's colitis: a novel approach to T-cell specific immunosuppressive therapy",
abstract = "A 33-year-old patient suffered from recurring Beh,cet's colitis despite treatment with corticosteroids and later cyclosporin. The patient was then successfully shifted from cyclosporin, a T-cell specific immunosuppressant, to fusidic acid treatment (500 mg t.i.d.). During fusidic acid treatment, he went into complete remission, and his prednisolone dose could be reduced from 30 to 5 mg/day. The case report substantiates recent in vitro data indicating that fusidic acid has a similar effect on T-cell function as cyclosporin. It is suggested that the effect of fusidic acid in other chronic immunoinflammatory diseases should be examined.",
keywords = "Adult, Behcet Syndrome/complications, Colitis/complications, Fusidic Acid/therapeutic use, Humans, Immunosuppressive Agents/therapeutic use, Male, T-Lymphocytes/drug effects",
author = "E Langholz and J Brynskov and Freund, {L G} and K Bendtzen",
year = "1991",
month = jun,
language = "English",
volume = "38",
pages = "284",
journal = "Danish Medical Bulletin (Print)",
issn = "0907-8916",
publisher = "Danish Medical Association and Danish Medical Society",
number = "3",

}

RIS

TY - JOUR

T1 - Fusidic acid for Behçet's colitis

T2 - a novel approach to T-cell specific immunosuppressive therapy

AU - Langholz, E

AU - Brynskov, J

AU - Freund, L G

AU - Bendtzen, K

PY - 1991/6

Y1 - 1991/6

N2 - A 33-year-old patient suffered from recurring Beh,cet's colitis despite treatment with corticosteroids and later cyclosporin. The patient was then successfully shifted from cyclosporin, a T-cell specific immunosuppressant, to fusidic acid treatment (500 mg t.i.d.). During fusidic acid treatment, he went into complete remission, and his prednisolone dose could be reduced from 30 to 5 mg/day. The case report substantiates recent in vitro data indicating that fusidic acid has a similar effect on T-cell function as cyclosporin. It is suggested that the effect of fusidic acid in other chronic immunoinflammatory diseases should be examined.

AB - A 33-year-old patient suffered from recurring Beh,cet's colitis despite treatment with corticosteroids and later cyclosporin. The patient was then successfully shifted from cyclosporin, a T-cell specific immunosuppressant, to fusidic acid treatment (500 mg t.i.d.). During fusidic acid treatment, he went into complete remission, and his prednisolone dose could be reduced from 30 to 5 mg/day. The case report substantiates recent in vitro data indicating that fusidic acid has a similar effect on T-cell function as cyclosporin. It is suggested that the effect of fusidic acid in other chronic immunoinflammatory diseases should be examined.

KW - Adult

KW - Behcet Syndrome/complications

KW - Colitis/complications

KW - Fusidic Acid/therapeutic use

KW - Humans

KW - Immunosuppressive Agents/therapeutic use

KW - Male

KW - T-Lymphocytes/drug effects

M3 - Journal article

C2 - 1868757

VL - 38

SP - 284

JO - Danish Medical Bulletin (Print)

JF - Danish Medical Bulletin (Print)

SN - 0907-8916

IS - 3

ER -

ID: 219531521